 Steve Groshong
Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Idiopathic Pulmonary Fibrosis | 14 | 2021 | 505 | 1.100 |
Why?
| | Lung Diseases, Interstitial | 12 | 2017 | 508 | 0.670 |
Why?
| | Lung | 23 | 2020 | 3561 | 0.620 |
Why?
| | Mucin-5B | 6 | 2018 | 183 | 0.450 |
Why?
| | Pulmonary Fibrosis | 6 | 2020 | 323 | 0.440 |
Why?
| | Tomography, X-Ray Computed | 10 | 2021 | 2286 | 0.430 |
Why?
| | Biopsy | 9 | 2019 | 1036 | 0.420 |
Why?
| | Fibroblasts | 6 | 2020 | 838 | 0.350 |
Why?
| | Bleomycin | 3 | 2020 | 228 | 0.310 |
Why?
| | Lung Diseases | 2 | 2018 | 701 | 0.310 |
Why?
| | Interdisciplinary Communication | 1 | 2009 | 183 | 0.310 |
Why?
| | Machine Learning | 3 | 2019 | 316 | 0.270 |
Why?
| | Bronchoscopy | 4 | 2018 | 245 | 0.260 |
Why?
| | Emergency Medical Technicians | 1 | 2006 | 41 | 0.250 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 371 | 0.240 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2020 | 86 | 0.240 |
Why?
| | Acute Lung Injury | 2 | 2022 | 299 | 0.230 |
Why?
| | Peritoneal Neoplasms | 1 | 2004 | 54 | 0.220 |
Why?
| | Diagnosis, Differential | 8 | 2020 | 1342 | 0.220 |
Why?
| | Teratoma | 1 | 2004 | 92 | 0.210 |
Why?
| | Middle Aged | 31 | 2021 | 26738 | 0.200 |
Why?
| | Research Report | 1 | 2022 | 75 | 0.190 |
Why?
| | Cough | 2 | 2015 | 107 | 0.190 |
Why?
| | Apoptosis | 4 | 2018 | 2363 | 0.190 |
Why?
| | Glioma | 1 | 2004 | 294 | 0.180 |
Why?
| | Bronchial Diseases | 2 | 2012 | 38 | 0.180 |
Why?
| | Lung Neoplasms | 4 | 2018 | 2177 | 0.180 |
Why?
| | Inflammation | 5 | 2022 | 2480 | 0.180 |
Why?
| | Biomarkers, Tumor | 4 | 2014 | 1040 | 0.170 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2020 | 23 | 0.170 |
Why?
| | Phenotype | 5 | 2015 | 2796 | 0.170 |
Why?
| | Myofibroblasts | 2 | 2018 | 116 | 0.170 |
Why?
| | Ovarian Neoplasms | 1 | 2004 | 388 | 0.160 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 448 | 0.160 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 13 | 1 | 2018 | 7 | 0.160 |
Why?
| | Common Variable Immunodeficiency | 1 | 2018 | 24 | 0.160 |
Why?
| | Aged | 20 | 2021 | 19074 | 0.150 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2009 | 58 | 0.150 |
Why?
| | Dihematoporphyrin Ether | 1 | 2018 | 3 | 0.150 |
Why?
| | Photochemotherapy | 1 | 2018 | 29 | 0.150 |
Why?
| | Photosensitizing Agents | 1 | 2018 | 26 | 0.150 |
Why?
| | Clinical Decision-Making | 1 | 2020 | 268 | 0.140 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 385 | 0.140 |
Why?
| | Humans | 44 | 2021 | 114698 | 0.140 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 2320 | 0.140 |
Why?
| | Complement C3 | 1 | 2018 | 188 | 0.140 |
Why?
| | Case-Control Studies | 8 | 2018 | 3003 | 0.130 |
Why?
| | Adenocarcinoma | 2 | 2018 | 795 | 0.130 |
Why?
| | Genomics | 1 | 2021 | 635 | 0.130 |
Why?
| | HLA-DQ beta-Chains | 1 | 2016 | 57 | 0.130 |
Why?
| | fas Receptor | 2 | 2018 | 91 | 0.130 |
Why?
| | HLA-DRB1 Chains | 1 | 2016 | 98 | 0.130 |
Why?
| | Female | 29 | 2021 | 59520 | 0.130 |
Why?
| | Genotype | 2 | 2018 | 1760 | 0.130 |
Why?
| | Genetic Loci | 2 | 2016 | 262 | 0.130 |
Why?
| | Male | 28 | 2021 | 55606 | 0.120 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 46 | 0.120 |
Why?
| | Genome-Wide Association Study | 3 | 2016 | 1177 | 0.120 |
Why?
| | Epithelial Cells | 4 | 2020 | 951 | 0.120 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2014 | 57 | 0.110 |
Why?
| | Receptors, Bombesin | 1 | 2014 | 2 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 961 | 0.110 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2013 | 25 | 0.110 |
Why?
| | Carcinoma, Small Cell | 1 | 2014 | 158 | 0.110 |
Why?
| | Dyspnea | 1 | 2015 | 211 | 0.110 |
Why?
| | Genetic Variation | 1 | 2018 | 870 | 0.110 |
Why?
| | Collagen | 2 | 2012 | 415 | 0.110 |
Why?
| | Mucin 5AC | 1 | 2013 | 48 | 0.100 |
Why?
| | Disease Models, Animal | 5 | 2018 | 3535 | 0.100 |
Why?
| | Adult | 16 | 2021 | 30553 | 0.100 |
Why?
| | Immunohistochemistry | 6 | 2018 | 1629 | 0.100 |
Why?
| | E2F1 Transcription Factor | 1 | 2012 | 57 | 0.100 |
Why?
| | Bronchi | 1 | 2013 | 232 | 0.100 |
Why?
| | Lymphatic Vessels | 1 | 2012 | 54 | 0.100 |
Why?
| | Algorithms | 1 | 2019 | 1470 | 0.100 |
Why?
| | Cilia | 1 | 2013 | 162 | 0.100 |
Why?
| | Trachea | 1 | 2013 | 224 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 808 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 2 | 2012 | 1003 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2012 | 823 | 0.100 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 58 | 0.090 |
Why?
| | Mice | 10 | 2020 | 14871 | 0.090 |
Why?
| | Sensitivity and Specificity | 3 | 2021 | 1693 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 1880 | 0.090 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2540 | 0.090 |
Why?
| | Animals | 13 | 2022 | 31708 | 0.090 |
Why?
| | Genetic Markers | 3 | 2021 | 320 | 0.090 |
Why?
| | Asthma | 2 | 2015 | 2029 | 0.090 |
Why?
| | beta Carotene | 1 | 2010 | 18 | 0.090 |
Why?
| | Peptides, Cyclic | 1 | 2012 | 253 | 0.090 |
Why?
| | Virus Replication | 2 | 2009 | 395 | 0.090 |
Why?
| | Pulmonary Medicine | 1 | 2011 | 87 | 0.090 |
Why?
| | Hemorrhage | 1 | 2014 | 620 | 0.090 |
Why?
| | Serum Amyloid A Protein | 1 | 2009 | 29 | 0.080 |
Why?
| | Pulmonary Alveoli | 2 | 2009 | 373 | 0.080 |
Why?
| | Coronavirus, Rat | 1 | 2009 | 1 | 0.080 |
Why?
| | Proteins | 1 | 2015 | 908 | 0.080 |
Why?
| | Prospective Studies | 6 | 2021 | 6220 | 0.080 |
Why?
| | Salivary Glands, Minor | 1 | 2009 | 8 | 0.080 |
Why?
| | Societies, Medical | 2 | 2011 | 664 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2012 | 720 | 0.080 |
Why?
| | Gene Expression Profiling | 5 | 2016 | 1518 | 0.080 |
Why?
| | CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 20 | 0.080 |
Why?
| | Signal Transduction | 2 | 2020 | 4515 | 0.080 |
Why?
| | Gammaherpesvirinae | 1 | 2009 | 38 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2009 | 110 | 0.080 |
Why?
| | Lymphoproliferative Disorders | 1 | 2009 | 46 | 0.080 |
Why?
| | Sjogren's Syndrome | 1 | 2009 | 41 | 0.080 |
Why?
| | Actinomycosis | 1 | 2008 | 3 | 0.080 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2009 | 63 | 0.080 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2009 | 112 | 0.080 |
Why?
| | Hypertension, Pulmonary | 2 | 2012 | 1729 | 0.080 |
Why?
| | Scleroderma, Limited | 1 | 2008 | 5 | 0.080 |
Why?
| | Herpesviridae Infections | 1 | 2009 | 138 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2021 | 2765 | 0.070 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 6 | 0.070 |
Why?
| | Granulomatosis with Polyangiitis | 1 | 2007 | 41 | 0.070 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 25 | 0.070 |
Why?
| | Foreign Bodies | 1 | 2008 | 96 | 0.070 |
Why?
| | Pneumonia | 2 | 2009 | 568 | 0.070 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 30 | 0.070 |
Why?
| | Autoantibodies | 2 | 2012 | 1346 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2009 | 275 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 385 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2020 | 3886 | 0.070 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 100 | 0.070 |
Why?
| | Pulmonary Artery | 1 | 2012 | 1016 | 0.070 |
Why?
| | Dietary Supplements | 1 | 2010 | 460 | 0.070 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6347 | 0.070 |
Why?
| | Mice, Knockout | 3 | 2018 | 2570 | 0.060 |
Why?
| | Missouri | 1 | 2006 | 61 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2009 | 719 | 0.060 |
Why?
| | Ambulances | 1 | 2006 | 50 | 0.060 |
Why?
| | Promoter Regions, Genetic | 3 | 2018 | 1131 | 0.060 |
Why?
| | Gene Expression | 3 | 2017 | 1421 | 0.060 |
Why?
| | Coronavirus Infections | 1 | 2009 | 330 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2009 | 1140 | 0.060 |
Why?
| | Retinoblastoma Protein | 1 | 2004 | 52 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 57 | 0.060 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 31 | 0.060 |
Why?
| | B-Lymphocytes | 1 | 2009 | 766 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 2018 | 182 | 0.050 |
Why?
| | Hysterectomy | 1 | 2004 | 106 | 0.050 |
Why?
| | Linkage Disequilibrium | 2 | 2016 | 245 | 0.050 |
Why?
| | Smoking | 1 | 2010 | 1383 | 0.050 |
Why?
| | Gene Frequency | 2 | 2015 | 477 | 0.050 |
Why?
| | Cohort Studies | 4 | 2017 | 4895 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1796 | 0.050 |
Why?
| | Disease Progression | 3 | 2020 | 2380 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2004 | 216 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2086 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 740 | 0.040 |
Why?
| | Interleukin-10 | 2 | 2014 | 299 | 0.040 |
Why?
| | Respiratory Function Tests | 2 | 2012 | 522 | 0.040 |
Why?
| | Retrospective Studies | 6 | 2014 | 12555 | 0.040 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2004 | 577 | 0.040 |
Why?
| | Macrophages, Alveolar | 2 | 2014 | 348 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 2 | 2014 | 811 | 0.040 |
Why?
| | Emergency Medical Services | 1 | 2006 | 590 | 0.040 |
Why?
| | Chronic Disease | 2 | 2018 | 1578 | 0.040 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 66 | 0.040 |
Why?
| | Drug Resistance, Microbial | 1 | 2018 | 66 | 0.040 |
Why?
| | A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
| | Rats | 3 | 2011 | 4958 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4694 | 0.040 |
Why?
| | Occupational Exposure | 1 | 2020 | 255 | 0.040 |
Why?
| | Reference Values | 1 | 2018 | 743 | 0.030 |
Why?
| | Dogs | 1 | 2018 | 334 | 0.030 |
Why?
| | Pneumonectomy | 1 | 2018 | 125 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2018 | 535 | 0.030 |
Why?
| | Breast Neoplasms | 1 | 2007 | 1862 | 0.030 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2016 | 44 | 0.030 |
Why?
| | ROC Curve | 1 | 2017 | 442 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 594 | 0.030 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 6 | 0.030 |
Why?
| | Phosphorylation | 1 | 2020 | 1569 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 8 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2009 | 1083 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 29 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 25 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 53 | 0.030 |
Why?
| | Neoplasms | 1 | 2009 | 2097 | 0.030 |
Why?
| | NF-kappa B | 2 | 2009 | 641 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 58 | 0.030 |
Why?
| | Auscultation | 1 | 2015 | 4 | 0.030 |
Why?
| | Herpesviridae | 1 | 2015 | 21 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 84 | 0.030 |
Why?
| | Neutrophils | 2 | 2011 | 1176 | 0.030 |
Why?
| | Hemosiderin | 1 | 2014 | 2 | 0.030 |
Why?
| | Cell Line | 2 | 2011 | 2637 | 0.030 |
Why?
| | Bleeding Time | 1 | 2014 | 6 | 0.030 |
Why?
| | Asymptomatic Diseases | 1 | 2015 | 75 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2013 | 2187 | 0.030 |
Why?
| | Young Adult | 3 | 2017 | 10471 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2015 | 150 | 0.030 |
Why?
| | Tetraspanin 24 | 1 | 2013 | 5 | 0.030 |
Why?
| | Integrin alpha6 | 1 | 2013 | 8 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 249 | 0.030 |
Why?
| | Fibrin | 1 | 2014 | 65 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2014 | 396 | 0.030 |
Why?
| | Thromboplastin | 1 | 2013 | 71 | 0.030 |
Why?
| | Clone Cells | 1 | 2013 | 247 | 0.030 |
Why?
| | Keratins | 1 | 2013 | 176 | 0.030 |
Why?
| | Chromosomes, Human | 1 | 2013 | 39 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor D | 1 | 2012 | 12 | 0.030 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 388 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2013 | 102 | 0.030 |
Why?
| | DNA, Viral | 1 | 2015 | 350 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor C | 1 | 2012 | 16 | 0.030 |
Why?
| | Lymphangiogenesis | 1 | 2012 | 24 | 0.030 |
Why?
| | Logistic Models | 1 | 2017 | 1841 | 0.030 |
Why?
| | Cysts | 1 | 2013 | 93 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2012 | 75 | 0.020 |
Why?
| | Alveolar Epithelial Cells | 1 | 2013 | 93 | 0.020 |
Why?
| | Blood Coagulation Factors | 1 | 2012 | 44 | 0.020 |
Why?
| | Regeneration | 1 | 2013 | 160 | 0.020 |
Why?
| | Airway Remodeling | 1 | 2012 | 57 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 610 | 0.020 |
Why?
| | Connective Tissue Diseases | 1 | 2012 | 71 | 0.020 |
Why?
| | Epoprostenol | 1 | 2012 | 133 | 0.020 |
Why?
| | Pulmonary Eosinophilia | 1 | 2011 | 25 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 57 | 0.020 |
Why?
| | Sex Distribution | 1 | 2012 | 337 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 396 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 133 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 251 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1075 | 0.020 |
Why?
| | Cytochromes | 1 | 2010 | 9 | 0.020 |
Why?
| | Cocarcinogenesis | 1 | 2010 | 14 | 0.020 |
Why?
| | Neovascularization, Pathologic | 1 | 2012 | 281 | 0.020 |
Why?
| | Spleen | 1 | 2012 | 487 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 294 | 0.020 |
Why?
| | alpha-Tocopherol | 1 | 2010 | 25 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 723 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2010 | 61 | 0.020 |
Why?
| | Endotoxins | 1 | 2011 | 211 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 812 | 0.020 |
Why?
| | Receptors, Retinoic Acid | 1 | 2010 | 49 | 0.020 |
Why?
| | Homeostasis | 1 | 2013 | 573 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2012 | 498 | 0.020 |
Why?
| | Ki-67 Antigen | 1 | 2010 | 103 | 0.020 |
Why?
| | Purpura | 1 | 2009 | 13 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2009 | 34 | 0.020 |
Why?
| | Bacterial Infections | 1 | 2011 | 218 | 0.020 |
Why?
| | Granuloma | 1 | 2009 | 83 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2009 | 73 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1226 | 0.020 |
Why?
| | Multicenter Studies as Topic | 1 | 2010 | 249 | 0.020 |
Why?
| | Adolescent | 3 | 2017 | 17853 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1168 | 0.020 |
Why?
| | Rats, Inbred F344 | 1 | 2009 | 241 | 0.020 |
Why?
| | Thrombosis | 1 | 2012 | 298 | 0.020 |
Why?
| | Elastin | 1 | 2009 | 78 | 0.020 |
Why?
| | Pulmonary Surfactants | 1 | 2009 | 99 | 0.020 |
Why?
| | Antihypertensive Agents | 1 | 2012 | 429 | 0.020 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 234 | 0.020 |
Why?
| | Myoblasts | 1 | 2009 | 76 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2008 | 16 | 0.020 |
Why?
| | Testicular Neoplasms | 1 | 2009 | 96 | 0.020 |
Why?
| | Leukocytes | 1 | 2009 | 276 | 0.020 |
Why?
| | Precision Medicine | 1 | 2011 | 337 | 0.020 |
Why?
| | Transcriptome | 1 | 2013 | 725 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2008 | 284 | 0.020 |
Why?
| | Phagocytosis | 1 | 2009 | 350 | 0.020 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 151 | 0.020 |
Why?
| | Lymphocytes | 1 | 2009 | 330 | 0.020 |
Why?
| | RNA | 1 | 2013 | 809 | 0.020 |
Why?
| | Pulmonary Circulation | 1 | 2009 | 407 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 797 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1211 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8632 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 136 | 0.020 |
Why?
| | Transfection | 1 | 2009 | 866 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 1701 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1144 | 0.020 |
Why?
| | Photomicrography | 1 | 2006 | 7 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 290 | 0.020 |
Why?
| | Colectomy | 1 | 2007 | 86 | 0.020 |
Why?
| | Rare Diseases | 1 | 2007 | 89 | 0.020 |
Why?
| | Lung Transplantation | 1 | 2008 | 246 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2009 | 993 | 0.020 |
Why?
| | MicroRNAs | 1 | 2012 | 600 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2007 | 135 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2010 | 1660 | 0.020 |
Why?
| | Acute Disease | 1 | 2008 | 911 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2009 | 676 | 0.020 |
Why?
| | Base Sequence | 1 | 2009 | 2114 | 0.020 |
Why?
| | Colonoscopy | 1 | 2007 | 204 | 0.020 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1214 | 0.020 |
Why?
| | Weight Loss | 1 | 2009 | 642 | 0.010 |
Why?
| | Biomarkers | 1 | 2015 | 3408 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2387 | 0.010 |
Why?
| | Liver | 1 | 2012 | 1637 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2006 | 1016 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2004 | 42 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2008 | 591 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 532 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 685 | 0.010 |
Why?
| | Cytokines | 1 | 2009 | 1841 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2553 | 0.010 |
Why?
| | Mutation | 1 | 2011 | 3346 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2007 | 4411 | 0.010 |
Why?
| | United States | 1 | 2011 | 12186 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 9088 | 0.010 |
Why?
|
|
Groshong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|